Psychiatric-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: A phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe

2012 ◽  
Vol 60 (5) ◽  
pp. S263
Author(s):  
M.L. Lecendreux ◽  
R.W. Dittmann ◽  
M. Gasior ◽  
T. Banaschewski ◽  
R. Civil ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document